We are live on ! Find out more
USNA icon

Usana Health Sciences

189 hedge funds and large institutions have $1.48B invested in Usana Health Sciences in 2018 Q2 according to their latest regulatory filings, with 46 funds opening new positions, 68 increasing their positions, 50 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more funds holding in top 10

Funds holding in top 10: 13 (+2)

109% more first-time investments, than exits

New positions opened: 46 | Existing positions closed: 22

42% more capital invested

Capital invested by funds: $1.04B → $1.48B (+$438M)

36% more repeat investments, than reductions

Existing positions increased: 68 | Existing positions reduced: 50

13% more funds holding

Funds holding: 168189 (+21)

2.81% more ownership

Funds ownership: 50.18%52.99% (+2.8%)

45% less call options, than puts

Call options by funds: $899K | Put options by funds: $1.64M

Holders
189
Holders Change
+21
Holders Change %
+12.5%
% of All Funds
4.33%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.07%
New
46
Increased
68
Reduced
50
Closed
22
Calls
$899K
Puts
$1.64M
Net Calls
-$740K
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Russell Investments Group
26
Russell Investments Group
United Kingdom
$14.6M -$1.18M -10,827 -8%
Man Group
27
Man Group
United Kingdom
$14.5M -$766K -7,005 -5%
Morgan Stanley
28
Morgan Stanley
New York
$14.3M -$78K -713 -0.6%
Bank of New York Mellon
29
Bank of New York Mellon
New York
$12.9M +$2.24M +20,510 +22%
FL
30
Fort LP
Maryland
$11.7M -$135K -1,233 -1%
Lazard Asset Management
31
Lazard Asset Management
New York
$11.4M +$10.8M +98,469 +36,069%
Two Sigma Advisers
32
Two Sigma Advisers
New York
$10.6M +$438K +4,000 +5%
Wells Fargo
33
Wells Fargo
California
$9.26M -$3.32M -30,368 -27%
Wellington Management Group
34
Wellington Management Group
Massachusetts
$9.26M -$701K -6,409 -7%
Federated Hermes
35
Federated Hermes
Pennsylvania
$9.24M +$5.37M +49,095 +158%
D.E. Shaw & Co
36
D.E. Shaw & Co
New York
$9.18M +$493K +4,508 +6%
PFC
37
Phocas Financial Corp
California
$8.34M -$73.3K -670 -0.9%
PPA
38
Parametric Portfolio Associates
Washington
$7.09M +$3.16M +28,849 +88%
GCP
39
GSA Capital Partners
United Kingdom
$6.83M +$2.42M +22,146 +60%
SCA
40
Secor Capital Advisors
New York
$6.78M +$1.61M +14,713 +33%
Ameriprise
41
Ameriprise
Minnesota
$6.54M +$1.49M +13,634 +32%
BIM
42
Bogle Investment Management
Massachusetts
$6.42M +$6.09M +55,672 New
UBS Group
43
UBS Group
Switzerland
$6.27M -$7.4M -67,653 -55%
APG Asset Management
44
APG Asset Management
Netherlands
$6.27M +$6.63M +60,600 +2,090%
AL
45
AJO LP
Pennsylvania
$5.67M +$2.6M +23,730 +93%
AllianceBernstein
46
AllianceBernstein
Tennessee
$5.33M -$2.76M -25,250 -35%
HI
47
HBK Investments
Texas
$5.21M +$3.58M +32,700 +262%
JP Morgan Chase
48
JP Morgan Chase
New York
$5.04M +$162K +1,481 +4%
Invesco
49
Invesco
Georgia
$4.72M +$2.91M +26,580 +186%
FQ
50
First Quadrant
California
$4.36M +$1.66M +15,191 +67%

USNA Hedge Fund Activity: Q2 2018 in Review

189 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Usana Health Sciences (USNA) for Q2 2018, worth a combined $1.48B — up 42% from $1.04B a quarter earlier.

Buyers outnumbered sellers: 46 funds opened new USNA positions and 22 closed out — a net gain of 24 holders — while 68 added to existing stakes and 50 trimmed.

The largest buyer was Acadian Asset Management, adding an estimated $51.9M. The largest seller was Fidelity Investments, cutting an estimated $80.7M.

  • 189 institutional investors held Usana Health Sciences (USNA) as of Q2 2018, up from 168 in Q1 2018.
  • Funds reported $1.48B of Usana Health Sciences stock for Q2 2018, up 42% quarter-over-quarter.
  • 46 funds opened new Usana Health Sciences positions in Q2 2018 and 22 closed out, a net change of +24 holders.
  • The largest Usana Health Sciences buyer in Q2 2018 was Acadian Asset Management, an estimated $51.9M added.
  • The largest Usana Health Sciences seller in Q2 2018 was Fidelity Investments, an estimated $80.7M sold.

Based on aggregated 13F filings for Q2 2018.